Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

Devansu Tewari; James J. Java; Ritu Salani; Deborah K. Armstrong; Maurie Markman; Thomas Herzog; Bradley J. Monk; John K. Chan

doi:10.1097/01.ogx.0000469913.56599.ae

Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

Devansu Tewari, James J. Java, Ritu Salani, Deborah K. Armstrong, Maurie Markman, Thomas Herzog, Bradley J. Monk, John K. Chan

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	505-506
Number of pages	2
Journal	Obstetrical and Gynecological Survey
Volume	70
Issue number	8
DOIs	https://doi.org/10.1097/01.ogx.0000469913.56599.ae
State	Published - Aug 29 2015

ASJC Scopus subject areas

Obstetrics and Gynecology

Access to Document

10.1097/01.ogx.0000469913.56599.ae

Cite this

Tewari, D., Java, J. J., Salani, R., Armstrong, D. K., Markman, M., Herzog, T., Monk, B. J., & Chan, J. K. (2015). Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study. Obstetrical and Gynecological Survey, 70(8), 505-506. https://doi.org/10.1097/01.ogx.0000469913.56599.ae

Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study. / Tewari, Devansu; Java, James J.; Salani, Ritu et al.
In: Obstetrical and Gynecological Survey, Vol. 70, No. 8, 29.08.2015, p. 505-506.

Research output: Contribution to journal › Comment/debate › peer-review

Tewari, D, Java, JJ, Salani, R, Armstrong, DK, Markman, M, Herzog, T, Monk, BJ & Chan, JK 2015, 'Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study', Obstetrical and Gynecological Survey, vol. 70, no. 8, pp. 505-506. https://doi.org/10.1097/01.ogx.0000469913.56599.ae

@article{42253827d6914d34ab48dd4b05ab86ae,

title = "Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study",

author = "Devansu Tewari and Java, {James J.} and Ritu Salani and Armstrong, {Deborah K.} and Maurie Markman and Thomas Herzog and Monk, {Bradley J.} and Chan, {John K.}",

year = "2015",

month = aug,

day = "29",

doi = "10.1097/01.ogx.0000469913.56599.ae",

language = "English (US)",

volume = "70",

pages = "505--506",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams and Wilkins",

number = "8",

}

TY - JOUR

T1 - Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer

T2 - A Gynecologic Oncology Group Study

AU - Tewari, Devansu

AU - Java, James J.

AU - Salani, Ritu

AU - Armstrong, Deborah K.

AU - Markman, Maurie

AU - Herzog, Thomas

AU - Monk, Bradley J.

AU - Chan, John K.

PY - 2015/8/29

Y1 - 2015/8/29

UR - http://www.scopus.com/inward/record.url?scp=84940549767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940549767&partnerID=8YFLogxK

U2 - 10.1097/01.ogx.0000469913.56599.ae

DO - 10.1097/01.ogx.0000469913.56599.ae

M3 - Comment/debate

AN - SCOPUS:84940549767

SN - 0029-7828

VL - 70

SP - 505

EP - 506

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

IS - 8

ER -

Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this